title: Chlamydia trachomatis control requires a vaccine.
abstract: As the most common reported communicable disease in North America and Europe, Chlamydia trachomatis is the focus of concerted public health control efforts based on screening and treatment. Unexpectedly control efforts are accompanied by rising reinfection rates attributed in part to arresting the development of herd immunity. Shortening the duration of infection through the testing and treatment program is the root cause behind the arrested immunity hypothesis and because of this a vaccine will be essential to control efforts. Advances in Chlamydia vaccinomics have revealed the C. trachomatis antigens that can be used to constitute a subunit vaccine and a vaccine solution appears to be scientifically achievable. We propose that an accelerated C. trachomatis vaccine effort requires coordinated partnership among academic, public health and private sector players together with a commitment to C. trachomatis vaccine control as a global public health priority.
authors: University of British Columbia and the British Columbia Centre for Disease Control, Vancouver, Canada. robert.brunham@bccdc.ca
authors: Robert C
authors: RC
authors: Brunham
authors: Rino
authors: R
authors: Rappuoli
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology; D002690:Chlamydia Infections / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D002692:Chlamydia trachomatis / Q000276:immunology; D014943:Global Health; D006291:Health Policy / Q000639:trends; D006801:Humans; D032521:Immunity, Herd; D011634:Public Health / Q000379:methods* / Q000639:trends; D022223:Vaccines, Subunit / Q000276:immunology
chemical_list: D001428:Bacterial Vaccines; D022223:Vaccines, Subunit
references: Infect Immun. 1983 Mar;39(3):1491-4
references: 6840846
references: J Immunol. 2008 Feb 15;180(4):2459-65
references: 18250455
references: J Med Microbiol. 2003 Jul;52(Pt 7):537-540
references: 12808072
references: Microb Comp Genomics. 1999;4(3):187-201
references: 10587946
references: J Immunol. 2010 Aug 1;185(3):1670-80
references: 20581152
references: Infect Immun. 1997 Jun;65(6):2175-82
references: 9169748
references: Cell. 2011 Dec 9;147(6):1212-5
references: 22153065
references: J Bacteriol. 2001 Apr;183(8):2686-90
references: 11274132
references: Infect Immun. 1990 Sep;58(9):3101-8
references: 2387636
references: Sex Transm Dis. 2008 Jan;35(1):53-4
references: 18157065
references: Infect Immun. 1981 Mar;31(3):1161-76
references: 7228399
references: MMWR Recomm Rep. 2002 Oct 18;51(RR-15):1-38; quiz CE1-4
references: 12418541
references: Infect Immun. 2001 Oct;69(10):6240-7
references: 11553566
references: J Immunol. 1998 Aug 1;161(3):1439-46
references: 9686609
references: J Immunol. 2009 Jun 15;182(12):8063-70
references: 19494332
references: J Infect Dis. 2005 Nov 15;192(10):1836-44
references: 16235186
references: J Bacteriol. 2006 Jan;188(1):275-86
references: 16352844
references: Sex Transm Dis. 1978 Apr-Jun;5(2):73-7
references: 10328037
references: Cell Microbiol. 2010 Feb;12(2):174-87
references: 19811502
references: Sex Transm Infect. 2008 Apr;84(2):87-91
references: 18216155
references: Infect Immun. 2009 Aug;77(8):3218-26
references: 19487469
references: Infect Immun. 1997 Aug;65(8):3361-9
references: 9234798
references: Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1477-91
references: 7601629
references: Infect Immun. 2012 Apr;80(4):1510-8
references: 22290151
references: PLoS One. 2012;7(6):e35616
references: 22701551
references: J Infect Dis. 1996 Jun;173(6):1437-44
references: 8648217
references: J Immunol. 2009 Feb 1;182(3):1602-8
references: 19155509
references: Infect Immun. 2011 Mar;79(3):986-96
references: 21078844
references: Sex Transm Infect. 1998 Jun;74 Suppl 1:S12-6
references: 10023347
references: J Infect Dis. 1996 Apr;173(4):950-6
references: 8603976
references: PLoS Pathog. 2011 Dec;7(12):e1002344
references: 22241978
references: Nat Rev Immunol. 2005 Feb;5(2):149-61
references: 15688042
references: N Engl J Med. 1984 Jul 5;311(1):1-6
references: 6427611
references: J Infect Dis. 1988 Sep;158(3):510-7
references: 3045213
references: J Infect Dis. 2013 Jan 1;207(1):30-8
references: 23100568
references: J Infect Dis. 2005 Aug 15;192(4):591-9
references: 16028127
references: N Engl J Med. 2003 Dec 18;349(25):2424-30
references: 14681509
references: Nat Rev Immunol. 2012 Feb 17;12(3):191-200
references: 22343568
references: J Immunol. 2012 Feb 15;188(4):1896-904
references: 22238459
references: PLoS Pathog. 2011 Sep;7(9):e1002258
references: 21966270
references: Sex Transm Dis. 1991 Jan-Mar;18(1):21-5
references: 1827541
references: J Infect Dis. 1999 Oct;180(4):1252-8
references: 10479155
references: J Gen Microbiol. 1993 Dec;139(12):2965-72
references: 7510322
references: J Infect Dis. 2009 Sep 15;200(6):926-34
references: 19656067
references: J Infect Dis. 1985 Dec;152(6):1275-82
references: 3840827
references: J Exp Med. 2011 Oct 24;208(11):2217-23
references: 21987657
references: MMWR Morb Mortal Wkly Rep. 2011 Apr 1;60(12):370-3
references: 21451447
references: J Infect Dis. 2005 Mar 15;191(6):907-16
references: 15717266
references: J Mol Med (Berl). 2010 May;88(5):451-8
references: 20217035
references: Obstet Gynecol. 1986 May;67(5):722-6
references: 3960443
references: Infect Immun. 2003 Mar;71(3):1200-8
references: 12595433
references: J Infect Dis. 2003 Aug 15;188(4):617-24
references: 12898452
references: J Bacteriol. 2010 Jun;192(11):2852-60
references: 20348250
references: FEMS Immunol Med Microbiol. 2009 Mar;55(2):162-6
references: 19159424
references: Infect Immun. 1991 Apr;59(4):1346-51
references: 1900810
references: Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1894-9
references: 16446444
references: Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9969-74
references: 21628568